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A PROSPECTIVE RANDOMISED STUDY ON COMPARISON OF 
INDUCTION DOSE REQUIREMENTS AND HEMODYNAMIC 
ALTERATIONS OF MIDAZOLAM-PROPOFOL AND PROPOFOL-
PROPOFOL COINDUCTION IN ELECTIVE GENERAL SURGERY 
ABSTRACT 
 
BACKGROUND OF STUDY 
Co-induction of anesthesia with Midazolam and Propofol with or without 
opioids can be considered as useful technique of induction of anaesthesia. The 
aim of the present study was to evaluate the efficacy of priming technique in 
relation to induction agents. Clinical efficacy in terms of dose reduction and 
alteration in peri-intubation haemodynamics was compared in Propofol-
Propofol and Midazolam -Propofol co-induction groups along with a control 
group. 
  
METHODS 
The study was carried out in 90 patients scheduled for elective general 
surgery, who were randomly divided into three equal groups. Group I received 2 
ml of normal saline(control group), group II received 0.05 mg/kg IV Midazolam 
and group III received 0.5mg/kg of Propofol. This was followed by IV 
induction with Propofol 2 minutes later in all the three groups at a 
predetermined rate till loss of response to verbal commands. Parameters like 
induction dose requirements and hemodynamic alterations are observed. 
 
RESULTS 
Using loss of response to verbal command and tolerance to placement of 
pace mask as end points, the dose of Propofol required to induce anaesthesia 
was significantly smaller in group-2 & group-3 (mean Propofol usage was 40.33 
and 69.00 respectively) when compared to control group (99.67) the total cost 
of induction was significantly reduced in the Midazolam co-induction group. 
 
CONCLUSION 
We conclude that Midazolam or Propofol predosing were equally 
effective in reducing the induction dose requirement of Propofol. Midazolam 
co-induction is more economical than Propofol predosing. Propofol –Propofol 
coinduction have better hemodynamics than Midazolam-Propofol group.  
 
Key words :  Propofol, Midazolam, Auto-co-induction. 
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INTRODUCTION 
For more than 70 years development of intravenous anaesthetics 
has been an important component of anaesthetic management. Prior to the 
development of intravenous anaesthesia, inhalation anaesthesia was 
practised. As Inhalation of gases was unpleasant to some patients, 
intravenous anaesthesia gained popularity. 
Intravenous anaesthesia followed the invention of hypodermic 
syringe and needle by Alexander wood in 1855. 
First successful attempt at intravenous anaesthesia in 1872 by 
Pierre Cyprien ore by using Chloral hydrate for anaesthetising patients. 
Other agents like Chloroform, Chloral hydrate, Ether were also used. 
Later the combination of Intravenous Morphine and Scopalamine 
by Brenfeld in 1916 gained popularity in obstetric anaesthesia. This was  
known as twilight sleep. But this combination was withdrawn due to side 
effects. 
 First Barbiturate named Barbituric acid  were discovered  in 1864, 
but it had no sedative action. Then barbiturate which had sedative action 
was discovered by Fischer von Mering in 1903. Diethyl barbituric acid 
was the first barbiturate used for induction of anaesthesia. Thiopentone 
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synthesized in 1932 by Volwiler and Tabern. It was first used clinically 
by John Lundy and Ralph Waters  in 1934, it remains most common 
induction agent for anaesthesia. Methohexital was used clinically in 1957 
by V.K.Stoelting. It was also used for induction of anaesthesia. 
According to Lundy General anaesthesia was safer with the use of 
multiple agents because the dose of particular agent was smaller and 
fewer side effects were observed. 
Then Ketamine  was synthesized in 1962 by Stevens. It was used 
clinically in 1965 by Corssen and Domino and released in 1970. 
Ketamine is a unique agent in the armamentarium of 
anaesthesiologist, as it does not depress the cardiovascular system even in 
full anaesthetic doses. 
Etomidate was introduced in 1973 and it was used for induction of 
anaesthesia. It produces only minimal hemodynamic depression and it 
gained popularity in anaesthetising patients with cardiac disease. Adrenal 
suppression was the major side effect seen with Etomidate. 
Then Propofol came into light in 1977.  It has achieved widespread 
use since its introduction. It was a major advance in outpatient 
anaesthesia because of its short duration of action and rapid recovery 
profile. Propofol is often administered as anaesthetic agent, with or 
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without the addition of inhaled anaesthetics. When combined with the 
analgesic agents such as Opioids, Propofol can provide all components of 
satisfactory general anaesthesia. Thus Propofol can be used in total 
intravenous anaesthesia (TIVA).    
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HISTORY OF PROPOFOL 
 First developed in 1976 by the  Imperial chemical industry .It was 
originally emulsified into Cremophor and clinical trials were 
conducted..But it was withdrawn from market due to high number of 
patients undergoing anaphylactic shock. Then reformulated into an 
emulsion of Soyabean oil and was released by Astra Zeneca 
pharmaceuticals in 1986.First clinical trial by Kay and Rolly in 1977, 
confirmed the potential of  Propofol as an anaesthetic  induction agent. 
He used 2%formulations with cremophor and alcohol. 
 
HISTORY OF BENZODIAZEPINES 
 The Benzodiazepines was extensively used for premedication, 
induction of anaesthesia and also used for intravenous sedation. 
Chlordiazepoxide was first Benzodiazepine synthesized in 1957. 
 Later other Benzodiazepines like Diazepam was synthesized in 
1959, Lorazepam was synthesized in 1971 and Midazolam was 
synthesized in 1976. 
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METHODS OF GENERAL ANAESTHESIA 
General anaesthetics are  compounds that induce a reversible loss 
of consciousness in humans or loss of righting reflex in animals. 
Clinically it also include the lack of awareness to painful stimuli. General 
anaesthetics do not act as analgesics and should also not be confused with 
sedatives. 
SITES OF ACTION 
General anaesthetics can interrupt central nervous system at different 
levels like spinal cord, brainstem, cerebral cortex, peripheral sensory 
neurons.  Delineation among action on anatomic sites is difficult, as they 
act diffusely and inhibit central nervous system. The different 
components of anaesthesia resulted by the action of anaesthetic agents on 
different sites. 
 Immobilisation in response to surgical incision is due to action on 
spinalcord. 
 Sedative action is due to involvement of the neuronal pathway in 
endogenous sleep. Propofol acts on GABA A in tuberomamillary 
neurons results in its sedative effect. Dexmedetomidine, an alpha 
agonist acts on locus ceruleus resulting in its sedative effect. 
Inhalation anaesthetics depresses the excitability of thalamic 
neurons which acts as a locus for its sedative action. 
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 Amnesia results from depression of  hippocampal neurotransmitter 
which acts as a locus for its amnesic effects. 
 
MECHANISM OF ACTION OF DRUGS  
LIPID THEORY 
At 20th century, Overton and Meyer described, General 
anaesthetics exert their action by acting on the plasma membrane. 
This was supported by evidence that the potency of the drug has a 
direct, positive correlation with the lipid solubility of the blood. The 
mechanism of action was proposed to be increased fluidity of the 
membrane. The interpretation of the Overton and Meyer finding has been 
challenged and discredited. 
CELLULAR MECHANISM 
General anaesthetics have two physiological effects at cellular 
level.  First, inhalation anaesthetics hyperpolarize neurons. Thereby 
reduced excitability in a postsynaptic neuron diminishes the likelihood of 
action potential initiated in response to neurotransmitter release. 
Second, at anaesthetic concentration, both intravenous and inhalation 
anaesthetic agents have effects on synaptic transmission and least action 
on action potential generation and propagation. 
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Inhalation anaesthetic agents inhibits excitatory synapses and 
enhances inhibitory synapses by their action on presynaptic and 
postsynaptic sites. 
 In postsynaptic site – it alters the response to released 
neurotransmitters via its action on receptors. 
 In presynaptic site – it decreases the neurotransmitter release by 
producing a small decrease in presynaptic action potential 
amplitude. This results in greater reduction in calcium influx in 
presynaptic site which is responsible for neurotransmitter release. 
Intravenous anaesthetics acts predominantly at synapses. It has its 
action profoundly on postsynaptic site. It acts predominantly by 
enhancing the release of inhibitory neurotransmitter. Ketamine is the only 
intravenous drug which inhibits excitatory neurotransmitter. 
MOLECULAR MECHANISM 
It is postulated that general anaesthetics exert their action through 
ion channels. 
The relative roles of different receptors is still under much debate, 
but evidence has emerged for some targets being involved with particular 
anaesthetics. 
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Multiple anaesthetics have been found to affect the inhibitory 
GABAA receptor, including Propofol, Thiopental and Isoflurane 
In clinical concentrations, inhalation anaesthetic agents enhance 
the capacity of Glycine to activate Glycine gated chloride channels. It 
inhibits neurotransmitter release at brain and spinalcord. 
In subanaesthetic concentration inhalation anaesthetics inhibits 
neuronal nicotinic acetylcholine receptors. This mediates analgesia, 
amnesia but not able to mediate immobilization for noxious stimuli. 
Only anaesthetic agents that donot have effect on GABA, Glycine 
receptors are Ketamine, Nitrous oxide, Cyclopropoane and Xenon. They 
act through NMDA receptors. 
 
Other channels are 
 Halogenated inhalation anaesthetic agents acts on a class of 
potassium channel. These are two pore domain channels. These 
channels are responsible for setting the resting membrane potential 
and may act as locus through which hyperpolarization of neurons 
occurs. 
 Inhalation anaesthetics may requires a protein complex. These 
protein complexes (synaptin, synaptobrevin, syntaxin) are involved 
in synaptic neurotransmitter release. This may be the cause for 
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presynaptic inhibition of neurotransmitter release in hippocampus, 
which is the site of action for amnesia.    
TWO MODES OF ADMINISTRATION (Induction) 
1. Inhalation technique 
2. Intravenous technique 
GUEDEL’S  STAGES OF ANAESTHESIA: 
There are four stages in general anaesthesia 
Stage I (Stage of analgesia or disorientation):  
From beginning of induction of general anesthesia to loss of 
consciousness. 
Stage II (Stage of excitement or delirium):  
        From loss of consciousness to onset of automatic breathing. During 
this stage eyelash reflex disappear but other reflexes remain intact and 
coughing, vomiting and struggling may occur. 
Respiration can be irregular with breath-holding. 
Stage III (stage of surgical anesthesia):  
        From onset of automatic respiration to respiratory paralysis. It is 
divided into four planes: 
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Plane I  - From onset of automatic respiration to cessation of 
eyeball movements. 
During this period Eyelid reflex and swallowing reflex 
disappears, marked eyeball movement may occur but 
conjunctival reflex is lost at the bottom of the plane 
Plane II - From cessation of eyeball movements to beginning of 
paralysis of 10ntercostals muscles. 
 Laryngeal reflex is lost although inflammation of the 
upper respiratory tract increases reflex irritability 
 Corneal reflex disappears 
 Secretion of tears increases (a useful sign of light 
anesthesia) 
 Respiration is automatic and regular  
 Deep breathing as a response to skin stimulation 
disappears. 
Plane III  - From beginning to completion of 10ntercostals muscle 
paralysis. Diaphragmatic respiration persists but there 
is progressive 10ntercostals paralysis 
 Pupils dilated and light reflex is abolished. 
 The laryngeal reflex lost in plane II can still be 
initiated by painful stimuli arising from the dilatation 
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of anus or cervix. This was the desired plane for 
surgery when muscle relaxants were not used. 
Plane IV - From complete intercostal paralysis to diaphragmatic 
Paralysis. However, xenon and nitrous oxide are 
thought to have no effect here. 
Stage IV: 
From stoppage of respiration till death. 
  Anaesthetic overdose can cause medullary paralysis with 
respiratory arrest and vasomotor collapse. Pupils are widely dilated and 
muscles are relaxed. 
In 1954 Joseph F. Artusio further divided the first stage in Guedel’s 
classification into three planes  
 1st plane –The patient does not experience amnesia or analgesia 
 2nd plane- The patient is completely amnesic but experiences only 
partial analgesia 
 3rd plane- The patient has complete analgesia and amnesia 
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INDUCTION 
Induction is a term that refers to the first stage of anaesthesia,      
Stage 1, prior to reaching a depth suitable for surgery i.e. Stage 3. 
The speed of induction depends on the time taken for the drug to 
reach an effective concentration in the brain. Different anaesthetic 
compounds reach   different compartments of the body, such as fatty 
tissue, muscle etc., at different rates. Hence, different compounds have 
different rates of induction. 
Intravenous anesthetics like Thiopental have been used for  
induction.  Propofol is now the most widely used intravenous induction 
agent. 
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PRINCIPLES OF SURGICAL ANAESTHESIA 
1. Minimizing the potentially deleterious effects of anesthetic agents 
and techniques. 
2. Sustaining physiologic homeostasis during surgical procedures that 
may involve major bloodloss, tissue ischemia, reperfusion of 
ischemic tissue, fluid shifts, exposure to a cold environment, and 
impaired coagulation. 
3. Improving postoperative outcomes by choosing techniques that 
block or treat components of the surgical stress response, which 
may lead to short- or long-term sequelae. 
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ELIMINATION OF ANAESTHETIC AGENTS 
Volatile anaesthetics are eliminated in the terminal phase via the 
lungs. A low blood:gas partition coefficient is therefore necessary for 
quick removal of the anaesthetic. When the oil:water coefficient is high, 
there will be little anaesthetic in the blood, so elimination will be slow, 
giving a prolonged hangover effect. 
Intravenous and intramuscular drugs are eliminated by metabolic 
pathways in the liver. It is not uncommon to produce toxic metabolites 
(e.g. chloroform). 
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SYNERGISM 
In Greek synergos- means working together  
Working together of two or more drugs to produce an effect greater 
than sum of their individual effect is known as synergism. 
In our study we took the synergistic action of Propofol and 
Midazolam. Both drugs act on GABA A receptor. But they act at 
different sites. GABA is major central nervous system inhibitory 
neurotransmitter. It produces fast inhibitory synaptic transmission. 
 Primary target of general anaesthesia is GABA receptor, whose 
inhibitory action is responsible for hypnosis, amnesia, anxiolysis. 
 Histaminergic neurons in posterior hypothalamus (tuberomamillary 
neurons) control wakefulness. Their silencing through GABA induces 
sleep.  
 Propofol and Midazolam have synergistic action in producing 
hypnosis. 
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GABA RECEPTOR 
          This receptor is a pentameric structure. These are the class of 
receptors that respond to neurotransmitter GABA. 
Types  of receptor 
 GABA A , GABA B,GABA C 
GABA A 
 Its a ligand gated ion channel. 
 Also known as ionotropic receptors. 
 Fast responding GABA receptors 
 Belongs to members of family of cys loop ligand ion channel. 
Members include nicotinic receptors, glycine, 5HT3 receptors. 
These form characteristic loop formed by disulphide bond between 
2 cystine residues 
 These are blocked by Biculline 
GABA B 
 Its  a G protein  coupled receptor. 
 Also called metabotropic receptors 
 Slow responding GABA receptors 
 These are not blocked by Biculline 
 
17 
 
GABA C 
 Its a allosteric  modulator of GABA A 
STRUCTURE                     
 Contains 5 subunits around a central core. Each subunit comprises 
four transmembrane domain with both N & C terminus located 
extracellularly. There are 6 types of subunits 
 Alpha 1,2,3,4,5,6 
 Beta 1,2,3 
 Gamma 1,2,3 
 Others are delta, rho, theta 
These five subunits can bind in different ways. Most common type of 
receptor contains 2 alpha, 2 beta subunits.  
Ligand GABA is endogenous compound that causes receptor to 
open resulting in flow of Chloride ions. Endogenous ligand that binds to 
Benzodiazepine site is Inosine. 
 While majority of GABA receptors (alpha 1,2,3,5) are 
Benzodiazepine sensitive there are subunits (alpha4,6)that are not 
Benzodiazepine sensitive but sensitive to neurosteroid and ethanol. 
Different Benzodizepines have different affinity for GABA 
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 Those binds to Alpha 1 & 5 results in sedation, amnesia 
 Those binds to Alpha 2 & 3 results in anxiolysis 
 Anticonvulsant activity occurs by binding to any receptors. Most 
commonly anticonvulsant binds to alpha 2 thereby reducing the 
side effects like amnesia. 
 Those binds to Beta 3 results in respiratory depression 
 Those binds to Beta 3 and 2 results in hypnosis  
Binding sites: 
 GABA binds between alpha and beta subunit 
 Benzodiazepines binds between alpha and gamma subunit 
  Propofol binds in beta subunit 
 Barbiturates binds at different site to GABA 
Both Propofol and Midazolam are GABA facilitatory Midazolam 
causes higher affinity to GABA, which results in potentiation of 
inhibitory effect of available GABA Propofol decreases the rate of 
dissociation of inhibitory neuron GABA thereby increases the 
duration of opening of chloride channel. 
 Benzodiazepines results in burst of Chloride channel to open. 
Barbiturates increases the duration of opening of channels. So 
Benzodiazepines and Barbiturates act synergistically. 
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Mechanism of action 
    GABA binds to GABA receptor extracellularly resulting in 
opening of Chloride channel. Entry of Chloride ions into cell results in 
more negativity of membrane potential. When membrane potential 
reaches around -65mv it results in hyperpolarisation thereby action 
potential does not develops. 
Binding of GABA in receptor 
Opening of Chloride channels   
Alters membrane potential –more negative 
  Prevents development of action potential 
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STRUCTURE OF GABA RECEPTOR 
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PROPOFOL 
MOLECULAR STRUCTURE OF PROPOFOL 
 
 
 
 
 
 
 
 
 
 
 
Is a substituted isopropylphenol(2,6 DIISOPROPYLPHENOL) 
Altering its side chain length influences its potency, induction, 
recovery. 
Not a chiral compound. 
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PREPARATION 
Its a insoluble drug requires a lipid vehicle for emulsification 
CURRENT FORMULATIONS - Contains 10% soyabean oil (as oil 
phase) &1.2%egg lecithin (for emulsification). It is made of long chain 
triglycerides and 2.25%glycerol  
This combination promotes bacterial growth and increase in 
triglycerides. Mixing with other drugs can result in coalescence of oil 
droplets with risk of pulmonary embolism. These demerits  resulted in the 
introduction of  different formulations. 
With respect to modification in preservatives Diprivan and Generic 
Propofol came to market. 
DIPRIVAN  - Contains 0.005% disodium edenate with NaOH 
as preservative (pH 7 – 8.5) 
GENERIC  - Contains sodium metabisulphite 0.25mg/ml as  
Preservative (pH 4.5-6.5) 
AMPOFOL - Contains 5% soyabean oil & 0.6% egg lecithin 
                          Low lipid emulsion formulations 
Not requires preservative 
Produces pain on injection 
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Then as an alternative to emulsion formulations and to avoid side 
effects of previous formulations Aquavan was introduced. 
AQUAVAN - Is a prodrug which acts by cleaving groups to  
    parent compounds(phosphate monoesters, 
hemisucccinates) Propofol is liberated after 
hydrolysis by endothelial surface alkaline  
Phosphatases. Thereby it increases water 
solubility (alternative to emulsion 
formulation).This drug  has larger volume of 
distribution and higher potency. 
 
ALONG WITH - Is an injectable form of Propofol. It is a 
CYCLODEXTRINS  nonlipid formulations. It is a ring sugar 
molecule. After injection propofol migrates out 
of it into the blood.  
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MECHANISM OF ACTION 
GABA A FACILITATORY 
GABA receptor on activation increases transmembrane 
conductance resulting in hyperpolarisation of postsynaptic cell membrane 
and functional inhibition of post synaptic neuron. 
 
 
  
25 
 
PHARMACOKINETICS 
ABSORPTION  - Only intravenous 
DISTRIBUTION  - Rapid onset due to high lipid solubility 
Rapid recovery with minimal residual  
Effects Less hang over so used in day 
Care 
BIOTRANSFORMATION- Both hepatic & extrahepatic 
IN LIVER : PROPOFOL undergoes ring hydroxylation by 
cytochrome p450 and get converted to 4 
hydroxypropofol (it has 1/3 hypnotic effect of 
propofol). 
4 hydroxypropofol then undergoes glucuronidation or 
sulfation into inactive metabolites and excreted 
through urine. 
 
IN LUNGS : Uptake of Propofol occurs and get transformed to  
2,6 di isopropylphenol 1,4 quiniol and released back 
to circulation.  
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MAJOR METABOLIC PATHWAY OF PROPOFOL 
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PLACENTAL CIRCULATION : Crosses placenta but rapidly 
cleared from neonatal 
circulation. 
 
DOSAGE  : 
INDUCTION OF ANAESTHESIA – 1.5 -2.5mg/kg iv 
 
IV INFUSION RATES : For sedation 25-75mic/kg/min 
For hypnosis 100-200 mic/kg/min 
 
ELIMINATION HALFLIFE : 0.5 – 1.5hours 
CONTEXT SENSITIVE HALF TIME 
Less than 40 mins for infusion of 8 hours 
 
VOLUME OF DISTRIBUTION : 3.5 – 4.5 l/kg 
CLEARANCE    : 30 – 60 ml/kg/min 
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EFFECTS OF ORGAN SYSTEMS 
CENTRAL NERVOUS SYSTEM 
  Propofol decreases CMRO2, cerebral blood flow, intracranial 
pressure. 
 Its antioxidant property may be the reason for its neuroprotective 
behaviour. 
 Cerebral autoregulation is not affected by Propofol. 
 At equidoses it produces same degree of memory impairment as 
Midazolam, whereas Thiopentone has milder effect. 
 EEG changes shows similar to Thiopentone, causing burst 
suppression in high doses. 
 Induction of Propofol is occasionally accompained by excitatory 
motor activity due to its subcortical glycine antagonism 
  Development of  tolerance to Propofol usage  is not seen. 
 
CARDIOVASCULAR SYSTEM 
 Fall in blood pressure is  greater compared to thiopentone. This is 
due to inhibition of sympathetic activity that results in loss of 
vasomotor tone leading to vasodilatation and due to its negative 
29 
 
ionotropic effect which is seen due to inhibition of 
transsarcolemmal calcium influx. 
 However Sympathetic response to intubation reverses the blood 
pressure effects of Propofol. 
 Compared to Thiopentone, Propofol blunts the pressor response to 
laryngoscopy. 
 It blunts baroreceptor reflexes so compensatory increase in heart 
rate does not occurs 
 Bradycardia and asystole can occasionally occur. This is due to 
greater predominance of Propofol on inhibition of sympathetic 
system. 
  Propofol induced bradycardia is treated with beta agonist 
 Hypotensive effects are exaggerated in hypovolemic patients, 
elderly,compromised  left ventricular function. 
 Also exaggerated when given in large doses and rapid injections. 
 
RESPIRATORY SYSTEM 
 Dose dependent depression of ventilation is seen, as it inhibits 
hypoxic ventilatory drive and also depresses normal response to 
hypercarbia. 
 Apnea occurs in 25-35% 
30 
 
 Hypoxic pulmonary vasoconstriction is not inhibited by 
Propofol. 
 It attenuates vagal induced bronchoconstriction. 
 Propofol induced depression of airway reflexes is greater than 
Thiopentone proves useful in intubation/LMA insertion in 
absence of paralysis. 
HEPATIC AND RENAL SYSTEM 
 Can be used in cirrhotic, renal failure patients 
 Prolonged infusion can produce hepatocellular injury, 
rhabdomyolysis 
 Urine may appear Green reflecting the presence of phenol or 
may appear cloudy due to crystallization of uric acid. This 
appearance in urine is not detrimental.   
INTRAOCULAR PRESSURE 
 It decreases intraocular pressure 
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USES 
 Induction of anaesthesia 
Dose of Propofol for induction in healthy adults is 1.5 – 2.5 mg/kg iv. 
Unconsiousness is produced when the Propofol blood level reaches 2 to 
6mic/kg. Children requires higher induction dose of Propofol reflecting a 
larger central distribution and higher clearance rate whereas elderly 
people requires lower induction dose reflecting smaller central 
distribution and decreased clearance rate. 
 Intravenous sedation 
The short effect site equilibration time and short context sensitive 
half time of Propofol makes it a titratable drug for intravenous 
sedation. The rapid recovery without residual sedation makes it 
suitable for day care surgery. For conscious sedation 25-100 
mic/kg/min iv dose of Propofol is needed. 
 Maintainance of anaesthesia 
Though Propofol is useful for ambulatory anaesthesia, its usage in 
long term surgery greater than two hours for maintenance of 
anaesthesia is questionable due to its high cost. Some found no 
difference in using Propofol as maintenance drug compared with 
inhalation agents. 
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 Antiemetic 
Propofol reduces the incidence of post operative nausea and 
vomiting and also chemotherapy induced vomiting. Propofol in       
subhypnotic dosage of around 10-15 mg iv acts as an antiemetic. The 
mechanism  of its antiemetic action is unclear. The antiemetic efficacy 
may be due to depression of subcortical areas or direct depression of 
vomiting centre. 
 Antipruritic 
Pruritis associated with intrathecal Opioids can be attenuated by 
Propofol. Dosage of  10mg iv is used as antipruritic. Propofol ability 
to depress the spinal cord activity is responsible for its antipruritic 
activity, as  intrathecal Opioids produce pruritis by segmental 
activation within spinal cord. 
 Attenuation of bronchoconstriction 
Propofol attenuates vagal induced bronchoconstriction. Thereby 
comparing to Thiopentone it decreases the prevalence of wheezing in 
asthmatic and healthy patients after induction and intubation. 
Preservative like metabisulphite can induce bronchoconstriction and 
such preparations must be avoided. 
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SIDE EFFECTS 
 Allergic reaction 
        Phenyl nucleus and diisopropoyl sidechain are the allergic 
components in Propofol. 
 Substance abuse 
 Bacterial contamination 
Propofol supports the growth of e.coli, pseudomonas. 
Therefore to prevent contamination aseptic precaution to be taken 
while handling. Immediately after opening the vial  the contents 
should be drawn to a sterile syringe and it should  be discarded if 
not used within 6 hours.  
 Pain on injection 
         Pain on injecting Propofol is reduced by selecting a larger 
vein or adding 1 ml of 2%lignocaine  to 18 ml of Propofol or 
addition of Opioids or changing the carrier fat emulsion 
composition. 
 Hypertriglyceridemia, pulmonary embolism 
 Lactic acidosis due to PROPOFOL INFUSION SYNDROME 
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 It occurs due to cytopathic hypoxia in those receiving more than 75 
mic/kg/min more than 24 hours. When there is unexplained tachycardia 
or increased anion gap in patients with Propofol infusion suspect lactic 
acidosis. The metabolic acidosis is reversible on discontinuation of 
infusion when diagnosed in early stages. 
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BENZODIAZEPINES 
       The term Benzodiazepines refers the portion of benzene ring fused to 
a seven membered diazepine ring.It is a 5 aryl 1,4 benzodiazepine 
structure. 
It has 5 pharmacological effects. Anxiolysis, Anticonvulsant 
actions, Anterograde amnesia, sedation, spinal cord mediated skeletal 
muscle relaxation. 
Compared to Barbiturates, they have less tendency to produce 
tolerance, abuse and greater margin of safety after overdose. 
Benzodiazepines not induce hepatic microsomal enzymes. Thus it 
replaces Barbiturates for preoperative medication  and sedation during 
monitored anaesthesia care. First Benzodiazepine was used in 1960. It  
was Chlorodiazepoxide. 
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CLASSIFICATION OF BENZODIAZEPINES 
ANXIOLYTICS 
 Diazepam 
 Clobazepam 
 Oxazepam 
 Alprazolam 
 Lorazepam 
HYPNOTIC 
 Nitrazepam 
 Flunitrazepam 
 Estazolam 
 Triazolam 
ANTIEPILEPTIC 
 Clonazepam 
ANAESTHETIC USAGE 
 Midazolam 
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MIDAZOLAM 
MOLECULAR STRUCTURE OF MIDAZOLAM 
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- Developed by HOFFMANN-LA-ROCHE IN 1970s. 
- It is a water soluble benzodiazepine. 
- It has imidazole ring in its structure which gives stability in 
aqueous solution and for rapid metabolism. 
- It is the most commonly used benzodiazepine. 
COMMERCIAL PREPARATION 
- Pk 6.15 
- Acidic pH 3.5 
- Midazolam characterised by pH DEPENDENT RING 
OPENING phenomenon 
- pH < 4 results in opening of ring which makes it water 
soluble 
- pH > 4 results in closure of ring which makes it lipid soluble 
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Its water soluble property obviates the need of solubilising 
preparation which is produces veno irritation. So Midazolam injection 
produces no discomfort. 
It can be mixed with acidic salts. 
PHARMACOKINETICS 
ABSORPTION  – Oral, im, iv. It undergoes first pass metabolism.  
DISTRIBUTION  – Lipid soluble thereby crosses blood brain 
barrier. But its slow effect site equilibration 
time (0.9-5.6 min) needs sufficient spacing 
between doses for its peak action to take place.  
VOLUME OF DISTRIBUTION – 1-1.5 l/kg 
ELIMINATION HALF TIME  – 1-4 hours 
CLEARANCE    – 6-8 ml/kg 
PROTEIN BINDING   – 96-98% 
Short duration of action of Midazolam is due to its lipid solubility, 
redistribution and  rapid hepatic clearance. 
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BIOTRANSFORMATION 
Midazolam is metabolised in liver and small intestine by 
cytochrome P450 into 4 hydroxymidazolam which is an inactive 
metabolite and 1hydroxymidazolam which is one half (1/2) potent as 
parent drug. This undergoes conjugation to form                                       
1-hydroxymidazglucuronide  then excreted in  urine. 
 
                                 MIDAZOLAM 
 
4 HYDROXYMIDAZOLAM            1 HYDROXYMIDAZOLAM 
 
                                                     1-HYDROXYMIDAZGLUCURONIDE 
 
                                                       EXCRETED THROUGH URINE 
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MECHANISM OF ACTION 
GABA A FACILITATORY 
Action on alpha subunit 1 is responsible for its sedative effect 
Action on alpha subunit 2 is responsible for its anxiolysis 
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EFFECTS ON ORGAN SYSTEM 
CARDIOVASCULAR SYSTEM 
 It decreases systemic vascular resistance thereby decreases blood 
pressure. 
 The effects on blood pressure is related to its plasma concentration. 
There is a ceiling effect above which little change in blood pressure 
occurs. 
 Cardiac output  is not altered. So Midazolam  can be used in 
congestive cardiac failure patients.  
 It does not prevents blood pressure and heart rate response to 
intubation. 
RESPIRATORY SYSTEM 
 Dose dependent decreases in ventilation  is seen with doses 
0.15mg/kg. 
 Midazolam 0.05 -0.075mg/kg shown to depress resting ventilation. 
 Transient apnea can occur. 
 Also depresses swallowing reflex and decreases upper airway 
activity. 
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CENTRAL NERVOUS SYSTEM 
 Decreases CMRO2, cerebral blood flow. Unlike Propofol it not 
produces isoelectric EEG due to its ceiling effect with respect to 
decrease in CMRO2 produced by increase in Midazolam doses. 
 Cerebral vasomotor responsiveness to CO2  is preserved 
 Potent anticonvulsant activity 
 Though it improves neurologic outcome, Benzodiazepines does not 
possess neuro protective activity. 
DOSAGE 
Sedation – 1-2.5 mg iv 
Induction – 0.1-0.5mg/kg iv 
Premedication – 0.05-0.15mg/kg iv 
USES 
 Most commonly used benzodiazepine for premedication 0.25 -
0.5mg/kg can be used as premedication to produce anxiolysis and 
sedation before 20-30 minutes of anaesthetic induction. 
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 Anterograde amnesia 
 
 
 
 
 
 
 
 
 
 Intravenous sedation 
      Compared to Diazepam, Midazolam produces rapid onset, 
greater amnesia and less post operative sedation. As age increases 
the hypnotic effect of Midazolam increases. 
 Induction of anaesthesia 
      Unlike Thiopentone induction of Midazolam is slower. Along 
with  small dose of Fentanyl ,unconsciousness is facilitated. Thus it 
has synergistic action with Fentanyl. 
 Maintenance of anaesthesia 
       Midazolam is usually administered to supplement Opioids, 
Propofol and inhalation agents. 
 Post operative sedation  
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SIDE EFFECTS 
 Fatigue 
 Drowsiness 
 Transient anterograde amnesia 
 Decreased motor co ordination and impairment of cognitive 
function 
 Tolerance develops to drug 
DRUG INTERACTIONS 
 Opioid and Midazolam  results in synergistic action 
 Decreases MAC value of volatile anaesthetic 
 Barbiturate potentiates the sedative effects 
  
46 
 
FLUMAZENIL 
Benzodiazepine antagonist used to treat an overdose of  
Benzodiazepines 
  
 
 
 
 
 
 
 
 
 It has high affinity to Benzodiazepine receptors 
 Acts as competitive antagonist 
 It is given intravenously 
 Plasma half life is 1 hour. Because of its short duration of action it 
has to be administered several times to maintain its effect. 
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THERAPEUTIC USES 
IN INTENSIVE CARE 
 For treatment of Benzodiazepine poisoning 
 Differential diagnosis of state of coma of unknown origin to reveal 
those poisoning with Benzodiazepines 
IN ANAESTHESIA 
 Interruption of general anaesthesia induced and maintained by 
Benzodiazepines 
 Interruption of sedation given by Benzodizepines 
 Treatment of hepatic encephalopathy where abnormal endogenous 
compounds involved as Benzodiazepine agonist 
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INDUCTION means making the patient sleep (hypnotic state) 
The term COINDUCTION of anaesthesia introduced in 1986. 
COINDUCTION means administering a small dose of sedative or 
anaesthetic agent prior to induction agent to reduce the dose required for 
induction 
AUTOCOINDUCTION is administering pre calculated dose of 
induction agent prior to induction with same induction agent 
PROPOFOL is a suitable alternative to Thiopentone for intravenous 
induction of general anaesthesia. Compared to Thiopentone, induction 
with Propofol is smooth, rapid onset and it has got better intubating 
conditions due to depression of airway reflexes. And also due to blunting 
of baro receptor reflexes compensatory increase in heart rate does not 
occurs. Rapid recovery with minimal residual effects and less hang over 
makes Propofol a wonderful drug for induction. Even though it has all 
these advantages, hypotension caused by propofol induction and its cost 
are worrisome. To overcome these demerits COINDUCTION OR 
PRIMING TECHNIQUE is used in our study. 
Our main aim is to improve the ratio of desired versus adverse effect 
of Propofol. Planned coinduction makes use of synergistic drug 
interactions between drugs. 
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By using this technique, we have undertaken this study to evaluate 
whether the coinduction of Propofol-Propofol or  Midazolam-Propofol  is 
better in terms of dose requirements and hemodynamic alterations 
compared to Propofol induction alone.      
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AIM OF STUDY 
 To compare Midazolam-Propofol coinduction with             
Propofol-Propofol coinduction in patients undergoing elective surgery 
with respect to 
Primary outcome 
 Total dosage of Propofol used  thereby finding cost effectiveness  
 Avoiding Propofol induced hypotension after induction. 
Secondary outcome 
 Hemodynamic alterations after intubation and 5 minutes ,10 
minutes after intubation. 
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REVIEW OF LITERATURE 
ANILKUMAR et al   conducted study in 100 ASA 1 & 2 patients of 
both sexes between 18-55 years, scheduled for elective surgeries under 
general anaesthesia. All patients allocated into two groups. 
GROUP 1 – CONTROL 
GROUP 2 -  STUDY 
IN GROUP 1 patients were induced with Propofol 2mg/kg whereas 
patients in GROUP 2 were initially primed with 20%calculated dose of 
Propofol 30 seconds prior and were later induced with remaining dose of 
Propofol until loss of eyelash reflex. 
The total induction dose requirements of Propofol and 
hemodynamic alterations were noted at various intervals like just before 
induction,one minute after induction ,immediately after intubation, five 
minutes after induction.. 
The data analysed by chi square and t test 
Mean dose of Propofol used in  
GROUP 1-108.12 
GROUP 2-78.4 
A mean reduction of 27.48% induction dose requirements of 
Propofol was observed in GROUP 2 (P VALUE=0.000000). 
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Likewise SBP,DBP,MAP  found to be increased after induction                                         
(P VALUE=0.000459) in Propofol group compared to control group.. 
Dr ROOPAM KATERIA et al  2010 Conducted a comparative study of 
efficacy of Propofol  autocoinduction versus Midazolam-Propofol  
coinduction using priming principle.  90 patients posted in upper 
abdominal surgery around 18-55 years of both sexes ASA 1 AND 2 
where randomly allocated into three groups of 30 each 
  GROUP 1 - Received 0.5mg/kg iv Propofol 
   GROUP 2 - Received 0.05mg/kg iv Midazolam 
  GROUP 3 - Received 3 ml normal saline 
Followed by iv induction with Propofol 2 minutes later till BIS 45 
attained 
The following were recorded 
        Total dose of Propofol required in achieving targeted 
BIS,HR,SBP,DBP,SPO2 just before induction, after induction, after 
intubation and 5 mins.  Post op recall phenomenon also enquired. 
They observed 31.8%reduction in induction dose of Propofol in 
Propofol autocoinduction group 45.37%reduction in induction dose of 
Propofol in Midazolam-Propofol group.(P<0.001) 
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Significantly lesser fall in both SBP,DBP, in Propofol 
autocoinduction group at postinduction interval. 
The rise in SBP,DBP after intubation was lesser in Propofol auto 
coinduction group(P<0.001) 
DR.UMA SRIVASTAVA et al Conducted study on smalldose of 
Propofol or Ketamine as an alternative to MIidazolam coinduction to 
Propofol. 
Studied in 68 patients of ASA 1 AND 2 of both sexes,aged 20-40 
years undergoing general,orthopaedic surgery were randomly allocated 
into 4 groups 
 GROUP KP- received 0.3mg/kg Ketamine 
GROUP MP-received 0.03 mg/kg Midazolam 
GROUP PP- received 0.4 mg/kg Propofol 
GROUP SP- received 3 ml normal saline 
Followed by Propofol induction till loss of verbal commands. 
Dose required to induce anaesthesia was significantly lesser in  
 GROUP KP-1.2 mg/kg 
 GROUP MP-1.4mg/kg 
 GROUP PP -1.6mg/kg 
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 Than CONTROL GROUP 2.7mg/kg 
Fall in BP was maximal in Control group, and it was least in 
Ketamine group. 
DR MINAXI H SHAH et al Conducted study on comparison of 
Midazolam-Propofol coinduction with Propofol predosing for induction 
of anaesthesia 
 Studied in 90 patients of ASA1 AND 2 aged 17-60 years of both 
sexes for elective day care surgery 
 GROUP 1 - Control 
 GROUP 2 - Received Midazolam 2mg iv 
 GROUP 3 - Received Propofol 30mg iv 
 Then induced with Propofol using loss of verbal command. 
They found in 
 GROUP 2 -38.26% 
 GROUP 3- 36.10% 
 Reduction in Propofol usage compared to Control group. 
Midazolam coinduction is more economical than Propofol predosing and 
also an effective method for reducing pain on injection with Propofol. 
 
55 
 
Dr DJAIANIG & RIBES et al Studied in 54 undergoing day care 
anaesthesia for minor  orthopaedic surgery. 
      GROUP 1-Midazolam 0.05 mg/kg iv 
      GROUP 2-Propofol 0.4mg/kg 
      GROUP 3- Normal Saline 
Followed 2 minutes later by Propofol infusion at a rate of  
50mg/kg/hr until loss of eyelash reflex. Compared pre and post induction 
hemodynamic changes, complications at insertion of LMA and recovery. 
They found in both GROUP 1 AND 2 reduction in Propofol usage 
compared to control GROUP 3. 
LEONG et al  Studied Propofol auto coinduction can aid LMA insertion 
44 ASA 1 AND 2 patients scheduled for surgery were randomly allocated 
into 2 groups. 
    GROUP 1-Propofol 0.5 mg/kg 
    GROUP 2-Normal saline 
Then Propofol infusion started at 50 mg/kg/hr till loss of eyelash 
reflex Observed significant difference in group 1 in requirement of 
Propofol. 
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N.A.JONES, S.ELLIOT et al   compared induction of anaesthesia in 
elderly patients with Midazolam-Propofol coinduction  and  Propofol  
predosing. 
They selected 60 patients of both sexes aged more than 70 years 
posted for urological surgery.60 patients divided to 20 each of three 
groups. 
                 GROUP 1- Midazolam 0.02mg/kg iv given 
                 GROUP 2-Propofol 0.25mg/kg iv given 
                 GROUP 3-Normal saline 2ml iv given 
After 2 minutes all these groups were induced with Propofol 
1%infusion 300ml/hr. End point of induction was taken as loss of 
response to verbal command and placement of oropharyngeal airway. 
Cardiovascular response monitored at 1 minute interval until induction 
was complete. 
They observed Group 1(Midazolam-Propofol ) had lesser 
requirement of Propofol than Group 3(placebo) P value=0.05,which 
shows it s significant 
There was no significant difference in dosage of Propofol  used 
while comparing Group 1 (Propofol group) with Group 3(placebo). 
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There was no demonstrable difference in terms of cardiovascular 
stability between three groups. 
DR MOHRIN NAZIR BUTT et al Compared Ketamine –Propofol and 
Midazolam-Propofol coinduction. 
Their primary outcome was the dose of Propofol required in two 
groups. They selected 60 patients of both sexes aged 20-50 years 
belonged to ASA 1 & 2 undergoing day care surgery. 
       GROUP K – Ketamine 0.3mg/kg iv 
       GROUP M – Midazolam0.03 mg/kg iv  
Followed by 2 minutes after induction with Propofol 10mg/5secs 
until patient stopped counting numbers and loss of verbal commands. 
They found mean induction dose between groups is not significant. 
GROUP K-53.67 
GROUP M-52.33  
P=0.78  Not significant                                                                
DR GOJENDRA RAJKUMAR,RUPENDRA THOKCHAM et al 
Compared coinduction of Midazolam, Thiopentone, Ketamine with 
Propofol in general anaesthesia. 120 patients posted for general and 
gynaecological surgery were allotted in 4 groups of  30  each. 
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GROUP 1 –Normal saline 2 ml 
GROUP 2 – Midazolam 0.03 mg/kg 
GROUP 3 – Thiopentone 1 mg/kg 
GROUP 4 – Ketamine 0.3mg/kg 
After 2 minutes all these groups were induced with Propofol 
30mg/10 secs until loss of response to oral commands or loss of eyelash 
reflex. Total induction dose of Propofol required and parameters like HR, 
SBP, DBP, MAP were monitored. 
Total induction dose requirements was decreased in group 2,3,4 
compared to control group 1. 
GROUP 2 -33.92%   
GROUP 3-35.08% 
GROUP 4-42.69% 
They observed fall in MAP from baseline in all the groups. 
GROUP 2-10.8% 
GROUP 3-14.58% 
GROUP4-8.37% 
They observed Ketamine reduced the induction dose requirements 
more compared with the other groups.   
59 
 
All three study groups provided hemodynamic stability but 
Ketamine group proved to be better than the other two study groups. 
YOUNG SOO LIM et al studied the Cardiovascular effects of 
Midazolam coinduction to Propofol  for induction of general anaesthesia 
in elderly patients. 
They conducted in 80 patients of more than 65 years undergoing 
general surgery. 
   GROUP 1 – 0.9%Nacl 0.03 ml/kg ,Propofol 1.2mg/kg,Remifentanyl 
   GROUP 2 – Midazolam 0.03mg/kg,Propofol 0.8mg/kg ,Remifentanyl 
Time taken for loss of consciousness and BIS at loss of 
consciousness were recorded. After loss of consciousness 0.8mg/kg of 
Rocuronium was given. All vital parameters noted. 
MBP at before intubation and 3 minutes after intubation was 
significantly reduced in both groups. Compared with Group 1,the 
decrease in MBP was less in Group 2.(p=0.05) 
Time taken to reach loss of consciousness was significantly 
reduced in Group 2 compared with Group1.(p<0.05) 
No significant difference in heart rate at any time between groups. 
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They concluded the study as, coinduction prevent a marked 
reduction in blood pressure at induction and after intubation in aged 
patients. 
MARTLEW  RA  MEAKING  G  et al  conducted  a study in children 
of age groups 3-12 years undergoing general anaesthesia for minor 
surgery to evaluate Midazolam premedication to Propofol induction . 
100 patients of two groups. 
GROUP 1- No premedication 
GROUP 2 –Oral Midazolam 0.5mg/kg   30 to 60 minutes before  
anaesthesia. 
Both groups were induced with Propofol iv over 15 seconds. 
Condition for LMA insertion assessed. Vitals and total dose requirements 
observed.  
Dose response curve were parallel in Group 1 (not pre medicated) 
but in Group 2 (pre medicated) shifted to left of not pre medicated curve. 
Propofol requirements also decreased by one third in pre medicated group 
compared to not pre medicated group.(p=0.0001) 
Dose required for LMA insertion in Group 1-3.8mg/kg  
                                                           Group 2-2.6 mg/kg 
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They concluded that Midazolam premedication to Propofol was 
better in children undergoing surgery. 
DRIVER  IK ,WILTSIRE S et al did a randomised trial on sedative 
premedication before Propofol induction. 
    Conducted study on 90 un premedicated patients undergoing elective  
gynaecological studies.90 patients were divided to three groups of 30 
each. 
GROUP P -  Propofol only 2.5mg/kg 
GROUP PA - Alfentanyl 10mic/kg 90 seconds prior to  
   Induction with Propofol 1.25mg/kg 
GROUP PMA- Midazolam 0.04 mg/kg 3 minutes, Alfentanyl  
10 mic/kg 90 seconds prior to Propofol 
induction of 1.25 mg/kg 
The end point of induction was taken as loss of response to verbal 
commands or eye lash reflex. If inadequate 0.25mg/kg every15 seconds 
was given. 
Vital signs like HR,SBP,DBP, mouth opening graded. 
They observed Group PMA  requires less Propofol consumption 
than other two groups(p<0.001). 
Group PMA  had  better mouth opening than other groups. 
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GOEL S BHARDWAJN et al did a randomised trial on Ketamine, 
Midazolam  coinduction with Propofol in general anaesthesia. Conducted 
in 60 children of age group 1-8 years. Alloted 3groups of 20 each. 
  GROUP P- Normal saline followed by Propofol 3.5mg/kg 
  GROUP PK- Ketamine 0.5mg/kg followed Propofol 2.5mg/kg 
  GROUP PM-Midazolam 0.05mg/kg followed by Propofol 2.5mg/kg 
And LMA inserted 30 seconds later. Vital signs were monitored. 
Group PK and Group PM found to be better than Group P with respect to 
LMA insertion.(p<0.05). 
There was fall in blood pressure in all three groups. Only 5% of 
patients in Group PK and Group PM showed more than 20% fall in SBP, 
where as 89% of patients showed  more than 20% fall in SBP.(P<0.0005) 
They concluded that Ketamine and Midazolam coinduction  with 
Propofol had better hemodynamic stability than induction with Propofol 
alone. Though they had better hemodynamics they were associated with 
delayed recovery.   
DR W M LEONG et al Conducted study on Propofol auto coinduction 
aid LMA insertion. They did in 44 patients in two groups undergoing 
general or orthopaedic surgery. 
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GROUP PP-0.5 mg/kg Propofol  2 minutes prior to induction 
GROUP CP-2 ml normal saline 2 minutes prior to induction 
Followed by 50mg/kg/hr till loss of eyelash reflex. 
They compared time taken for induction and LMA insertion, total 
dose of  Propofol needed,hemodynamics. 
Significant reduction in dose  was seen in Group PP than Group CP. 
GROUP PP-100     
GROUP CP-166 (P=0.0001) 
Jaw opening was ease with Group PP 
Significant reduction in MAP in each group seen after induction. 
But the magnitude of decrease in each group  was not significant between 
groups. 
Thus they concluded Propofol  autocoinduction was better in LMA 
insertion than inducing with Propofol alone. 
DONALD  C OXAN et al studied the effects of Midazolam on Propofol 
induced anaesthesia withrespect to Propofol dose requirements,mood 
profiles and perioperative dreams. 
They conducted in females undergoing dilatation and curettage 
surgery.60 patients of 30 each in two groups were allotted. 
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GROUP 1 – Midazolam 30 mic/kg 
GROUP 2-  Placebo 
Followed by induction with Propofol. Loss of verbal contact was 
taken as end point of induction. Vitals monitored. 
They didn’t find any significant difference in dose of Propofol 
required to induce hypnosis or maintain anaesthesia.  
Dr DIMPLE WALLY et al compared Propofol predosing with 
Midazolam coinduction in LMA insertion. 
Conducted on 60 patients in three groups of 20 each 
GROUP 1 – Normal saline 
GROUP 2 – Midazolam  
GROUP 3 - Propofol   
All three groups were followed by Propofol induction. Vitals were 
monitored. 
HR, SBP, DBP, MAP were decreased in all three groups. 
Induction dose in  Group 2-106.3 
Group 3-136.5 
Group 1-159.75 
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No statistical difference observed between Group 2 and Group 3  
with respect to dose of Propofol required. But was significant when 
compared with control group. 
They concluded that Midazolam coinduction and Propofol auto 
coinduction  were safe alternative to induction of  Propofol alone. 
With respect to cost effectiveness Midazolam coinduction was 
more economical and better than Propofol coinduction. 
ANDERSON  H  ROBB et al studied the comparison of  Midazolam 
coinduction  with Propofol predosing  for induction of  general 
anaesthesia . 
Conducted on 90 patients  of ASA 1&2 of both sexes. Divided into 
three groups of  30 each. 
GROUP 1- Midazolam 2 mg 
GROUP 2-Propofol 30 mg  
GROUP 3- placebo 
Followed by Propofol induction till loss of verbal contact and 
tolerance to placement of facemask. 
Requirement of Propofol in Group 1-1.71mg/kg 
                                             Group 2-1.87mg/kg 
                                             Group 3-2.38m/kg 
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 Predosing decreases Propofol usage in both study groups 
compared to control group. They observed  no  significant  difference in 
hemodynamics. 
J.A LEITCH, ANDERSON at al conducted randomised trial on patients 
maintained in Propofol sedation &operator controlled Midazolam 
sedation in third molar extraction 
Two groups were compared before, during and after sedation. 
1. Their primary outcome were time until discharge 
2. Oxygen saturation 
Vital signs, anxiety, psychomotor skills were also compared. 
Anxiety decreased greater in Propofol group(P=0.010) 
Propofol group recovered quicker (P=0.010). Smaller decrease in 
saturation(p<0.001).smaller decrease in heart rate(p<0.001) 
Thus Propofol produces superior anxiolysis, quicker recovery, less 
amnesia, less depression of psychomotor function. 
NI NI WIN KCHASE et al Conducted trial on hemodynamic changes 
during Midazolam Propofol coinduction. Conducted in 40 patients of 20 
each in two groups. 
          GROUP 1 – Propofol 2.5mg/kg 
          GROUP 2 –Midazolam 0.1mg/kg followed  by Propofol 1.5 mg/kg 
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Parameters like LF(low frequency component) which reflects both 
cardiac sympathetic and parasympathetic activity. 
HF (high frequency component) which reflects cardiac 
parasympathetic activity 
TOTAL POWER calculated by LF+HF and LF/HF RATIO which 
reflects balance between cardiac sympathetic and parasympathetic 
activity. 
In Group 2- significant increase in LF/HF ratio observed before 
intubation, after intubation. 
Thus Midazolam Propofol coinduction  is better in preserving 
hemodynamics reduction in dose and time taken for LMA insertion in 
Propofol group. 
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MATERIALS AND METHODS 
               This study was approved by our Institutional Ethics Committee, 
and it was conducted in our Institute of anaesthesiology and critical care. 
Madras Medical College, Rajiv Gandhi general hospital, Chennai. The 
study was a Prospective, Randomised controlled study. 
                This study was conducted on 90 patients of ASA 1 & 2 of both 
sexes undergoing elective surgery 
INCLUSION CRITERIA 
 Age    :  18 – 60 years 
 ASA   :  1 & 2 
 Weight : 40 – 80 kg 
 Surgery :elective 
 Who have given valid informed consent 
EXCLUSION CRITERIA 
 Not satisfying inclusion criteria 
 Lack of written informed consent 
 Patients undergoing Emergency surgery 
 Pregnant females 
 Difficult airway 
 Allergic to medications 
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MATERIALS 
 Drugs – inj Glycopyrrolate, inj Fentanyl, inj Midazolam,inj 
Propofol, inj Succinylcholine, Non depolarising muscle 
relaxants, volatile agents, all other emergency drugs 
 Laryngoscope with different size blades, bougie, airways 
 Different sizes of endotracheal tubes 
 Monitors – ECG, NIBP ,SPO2 
 Suction apparatus 
METHODS 
The patients who satisfied the above inclusion criteria were 
included in this study after getting a valid informed consent from them. 
      The three groups were randomised by lot system into 
             GROUP 1  - Received normal saline 2 ml 
             GROUP 2  - Received Midazolam 0.05 mg/kg iv 
             GROUP 3  - Received Propofol 0.5 mg/kg iv 
All this group then induced with Propofol 2 minutes later. The end 
point of induction is taken as loss of response to verbal commands. 
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PREOPERATIVE 
            Age, weight, comorbid conditions, any history of previous 
surgery, vitals  like pulse rate, blood pressure,spo2,baseline investigations 
like haemoglobin, blood sugar, blood urea, serum creatinine, serum 
electrolytes, ECG, Chest X ray were checked. Thorough systemic 
examination and airway examination were done and patients were 
selected in this study and allocated into groups. 
INTRAOPERATIVE 
         90 patients of age group 18-60 years of both sexes belonging to 
ASA 1&2 posted for elective surgery were allocated into 3 groups of 30 
each by lot system. 
Patients were shifted to operating room as scheduled. Monitors 
were connected and baseline parameters like heart rate, blood 
pressure,spo2 were recorded. Baseline value recorded as an average of 
three readings taken 5 minutes apart before 10 minutes of starting the 
general anaesthesia. Patients were given Inj. Glycopyrrolate 10 mic/kg iv, 
Inj .Fentanyl 2 mic/kg iv ten minutes before starting and pre oxygenated 
with 100% oxygen. 
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Then according to group stratification  
       GROUP 1 - Received normal saline 2ml 
       GROUP 2 - Received Midazolam 0.05 mg/kg iv 
       GROUP 3 - Received Propofol 0.5 mg/kg iv 
After two minutes patients of all three groups are induced with 
Propofol till loss of response to verbal command as end point. Propofol 
induced at a rate of 10 mg/10secs. This speed is kept constant in all three 
groups. After loss of response to verbal commands anatomical mask was 
kept over the patient face, if there was any resistance on keeping mask 
over face additional bolus of 10 mg given till  there was no disturbance in 
holding mask. Complications like apnea, laryngospasm, vomiting, 
coughing are noted. 
Then the patients were given muscle relaxant Succinylcholine 2 
mg/kg iv and intubated with appropriate size endotracheal tube and 
ventilation was controlled. Anaesthesia was maintained by using           
O2 : N2O (33:66) and volatiles like sevoflurane, desflurane. Non 
depolarising muscle relaxant  like Atracurium used as muscle relaxant 
intraoperatively. Surgery started after 10 mins. During this period no 
stimuli applied to patient. 
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Parameters like Heart rate, systolic blood pressure, diastolic blood 
pressure, oxygen saturation were recorded just before induction, after 
induction, after intubation, after 5 minutes and 10 minutes of intubation. 
Total dose of Propofol used also noted. 
After procedure patients are extubated and sent to post operative 
wards. 
PRIMARY OUTCOME MEASURES 
 Total dose of Propofol needed 
 Hemodynamic alterations just before induction, after induction 
SECONDARY OUTCOME MEASURES 
 Hemodynamic alterations after intubation, 5minutes and 10minutes 
after intubation. 
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STATISTICAL ANALYSIS 
        Statistical analysis was done using statistical package for social 
sciences windows  version 15.Results expressed in this study were given 
as mean and standard deviation. 
All continuous variables like age, weight, HR, SBP, DBP, MAP 
were compared using ANOVA (ANALYSIS OF VARIANCE)  
Chi square test used to compare between sex and ASA 
P value <0.05 was considered significant 
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OBSERVATION AND RESULTS 
 
DEMOGRAPHIC DATA 
       The three groups were compared with respect to age, sex, weight  
and ASA physical status. The results were discussed as follows:  
 
                             TABLE – 1: AGE DISTRIBUTION 
             
 
 
 
 
GROUPS N Mean Std. Deviation 
ANOVA 
F value 
P 
value Significance 
Control 30 38.50 11.557 .471 .626 NS 
Midazolam-Propofol 30 41.73 13.903    
Propofol-Propofol 30 41.00 14.923    
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 P VALUE of 0.626 derived for age distribution among three 
groups, which is not statistically significant. This shows we have 
compared similar age group patient. 
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TABLE – 2 : SEX DISTRIBUTION 
 
 
 
  
SEX 
Group  
Control Midazolam-Propofol 
Propofol-
Propofol 
Chi-
square 
N % N % N %  
Female 14 46.7% 15 50.0% 15 50.0% 
0.089, 
P>0.05 
NS 
Male 16 53.3% 15 50.0% 15 50.0%  
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 P value of 0.089 derived among three groups, which showed no 
significant difference between groups. It shows we have compared 
similar sex between groups. 
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TABLE – 3: WEIGHT DISTRIBUTION 
 
 
  
Group N Mean Std. Deviation 
ANOVA 
F value 
P 
value Significance 
Control 30 58.67 7.189 .978 .380 NS 
Midazolam+Propofol 30 61.67 8.999    
Propofol+Propofol 30 60.53 8.862    
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 We got P value of 0.380 in weight distribution among three groups, 
which is not significant between groups. 
 This showed we compared three groups of similar weight patients. 
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TABLE – 4 : ASA STATUS OF GROUPS 
 
ASA 
Group 
Chi-square 
Control Midazolam-Propofol 
Propofol-
Propofol 
N % N % N %  
1 24 80.0% 23 76.7% 24 80.0% 0.133 
2 6 20.0% 7 23.3% 6 20.0% P>0.05 NS 
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 With respect to ASA status, we didn’t find any significant 
difference between three groups. We got P value of 0.13 which showed 
no significance in groups. 
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TABLE – 5: HEART RATE VARIATIONS 
HR 
 
Control Midazolam-Propofol 
Propofol-
Propofol  
F 
 
P 
value Mean SD Mean SD Mean SD 
Baseline 87.83 13.42 90.70 13.58 90.77 16.18 .403 .669 
Before 
Induction 85.47 12.80 83.23 10.96 84.17 14.74 .226 .798 
After 
Induction 79.40 12.16 80.43 10.29 80.93 12.33 .136 .873 
After 
Intubation 99.10 12.86 96.43 10.93 87.70 14.43 6.491 .002* 
5 Mins 94.23 11.05 88.80 8.50 86.47 13.26 3.862 .025* 
10 Mins 86.73 10.04 86.43 9.66 83.57 11.65 .834 .438 
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 There was no significant changes in heart rate variation between 
three groups in recordings taken just before induction, after induction, 10 
minutes after intubation. 
 Heart rate variations was found to be significant in recordings 
taken after intubation, 5 minutes after intubation among three groups. 
 Increase in heart rate after intubation was greater in control group, 
and found to be least in Propofol group. (p=0.002) 
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TABLE 6 : VARIATIONS IN SYSTOLIC BLOOD PRESSURE 
SBP 
 
Control Midazolam +Propofol 
Propofol 
+Propofol  
F 
P 
value 
Mean SD Mean SD Mean SD 
Baseline 117.53 9.85 121.07 11.10 123.70 10.00 2.691 .073 
Before 
Induction 118.43 9.63 112.40 10.12 114.53 9.19 3.012 .054 
After 
Induction 101.47 10.05 106.23 10.59 108.80 9.47 4.115 .020* 
After 
Intubation 120.93 12.81 126.93 9.94 117.67 12.18 4.833 .010* 
5 Mins 115.00 9.64 118.20 11.29 110.40 12.47 3.682 .029* 
10 Mins 113.60 9.21 115.13 8.48 109.33 10.31 3.092 .050 
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PRESSURE 
 
 We found significant difference in readings taken after induction, 
after intubation, 5 minutes after intubation among three groups. There 
was no significant difference seen 10 minutes after intubation. 
 In our study SBP after induction falls greater in control group, and 
it was least in Propofol-Propofol group (p =0.020). 
 SBP after intubation was greater in control group and it was least 
in Propofol-Propofol group (p=0.010). 
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TABLE 7: VARIATIONS IN DIASTOLIC BLOOD PRESSURE 
 
 
             
  
DBP 
 
Control Midazolam +Propofol 
Propofol 
+Propofol  
F 
 
P value Mean SD Mean SD Mean SD 
Baseline 79.53 8.72 79.43 7.01 79.87 5.66 .029 .971 
Before 
Induction 77.93 8.23 73.03 7.08 73.50 7.73 3.706 .029* 
After 
Induction 64.77 9.60 66.83 7.94 68.27 7.24 1.342 .267 
After 
Intubation 86.30 6.11 85.03 4.76 78.27 6.94 15.520 P<0.01* 
5 Mins 83.97 6.87 82.90 6.79 75.90 5.24 14.309 P<0.01* 
10 Mins 80.80 7.36 76.83 6.27 76.83 6.77 3.387 .038* 
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We found variations of diastolic blood pressure are significant 
between three groups in readings noted in after intubation, 5 minutes after 
intubation. There was greater rise in DBP seen after intubation in control 
group, and it was least in Propofol-Propofol group(p=<0.01). There was 
no difference seen 10 minutes after intubation. 
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 TABLE 8 : VARIATIONS IN MEAN BLOOD PRESSURE 
 
           
 
        
 
 
 
 
 
MAP 
 
Control Midazolam-Propofol 
Propofol-
Propofol  
F 
 
P value 
Mean SD Mean SD Mean SD 
Baseline 92.20 8.79 93.31 7.71 94.48 6.47 .653 .523 
Before 
Induction 91.43 8.40 86.16 7.08 86.92 6.68 4.431 .015* 
After 
Induction 77.00 9.31 79.97 7.69 82.24 5.99 3.425 0.037* 
After 
Intubation 97.84 7.57 99.00 5.58 91.40 8.06 9.836 P<0.01* 
5 Mins 94.31 7.05 94.67 6.58 87.40 6.62 11.030 P<0.01* 
10 Mins 91.56 6.49 89.60 5.56 88.02 7.14 2.274 .109 
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GRAPHICAL REPRESENTATION OF TRENDS IN MAP 
 
 Mean arterial blood pressure was found to be significant in 
recordings noted on after induction, after intubation, 5 minutes after 
intubation. There was no difference noted after 10 minutes of intubation. 
After induction MAP was greater in Propofol-Propofol group, and it was 
least in control group (p=0.037). 
 After intubation MAP variations showed significant difference 
between the groups.MAP was greater in control group, and it was least in 
Propofol-Propofol group (p<0.01). 
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TABLE 9 : TOTAL DOSE OF PROPOFOL USED 
 
GROUP N Mean SD ANOVA F value P value Significance 
Control 30 99.67 9.994 
228.350 P<0.001 S Midazolam-Propofol 30 40.33 9.279 
Propofol-Propofol 30 69.00 12.690 
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GRAPHICAL REPRESENTATION OF TOTAL PROPOFOL 
USED 
 
 
 There was significant reduction in usage of Propofol among three 
groups. We found greater reduction in Midazolam-Propofol group 
(p<0.001). 
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DISCUSSION 
 In this study on 90 patients of 30  each in three groups we were 
comparing the Midazolam-Propofol group and Propofol-Propofol group 
in terms of total dose requirements of induction agent Propofol and 
hemodynamics after induction, hemodynamics after intubation and 
hemodynamics after 5  & 10 minutes of intubation with control group. 
 
HEART RATE 
 On comparing the heart rate between groups, there was no 
significant difference in heart rate after induction. 
 After intubation heart rate is increased in all three groups. 
 In control Group – 99.10 
 In Midazolam-Propofol Group-96.43 
 In Propofol-Propofol Group-87.70 
 Heart rate was increased maximum in control group compared to 
other two groups. 
 Heart rate was increased greater in Midazolam–Propofol group 
compared to Propofol-Propofol group. Thus there was significance in 
heart rate variations after intubation. (P value =0.002) There was no 
difference seen after 10 minutes of intubation. 
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 Similar results was obtained by Kataria et al19 studies where heart 
rate increased in all three groups with least in Propofol auto coinduction 
group after intubation. They also noted significant fall in heart rate in 
Propofol group in post priming period. 
 This observation may be due to the reason that Midazolam does not 
prevent increase in heart rate that occurs due to intubation. Unlike 
Thiopentone Propofol prevents compensatory increase in heart rate due to 
blunting of baroreceptor reflex.  
 
MEAN SYSTOLIC BLOOD PRESSURE 
In our study Mean SBP falls after induction in all three groups. 
 In control group from 118 to 101 
 In Midazolam-Propofol group from 112 to 106 
 In Propofol-Propofol group from114 to 108 
In our study P value of 0.020 obtained which shows significant 
difference between groups. There was fall in Systolic blood pressure after 
induction which was greater in control group and was least in other two 
groups. 
Mean Systolic blood pressure was increased after intubation, 5 
minutes after intubation in all three groups. 
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 In control group-120.93 
 In Midazolam –Propofol group-126.93 
 In Propofol-Propofol group-117.67 
P=0.010 showed significant difference between groups.  
 There was greater rise in control group compared to          
Propofol–Propofol group after intubation. We found greater rise in mean 
systolic blood pressure in Midazolam-Propofol group compared to 
Propofol- Propofol group after intubation. 
 In studies by ANILKUMAR20 et el Mean SBP in Propofol auto 
coinduction group was higher after induction (p=0.000002) after 
intubation (p=0.00000)   5minutes (p=0.00000) 
 In a study by KATERIA19 et al Mean SBP falls in all groups. 
20%increase in Mean SBP obtained in Midazolam group after intubation. 
 In a study conducted by GOEL S BHARDWAJAN29 et al SBP 
falls >20% in 80%of control group compared to only 5% in Propofol 
Ketamine group. 
 In studies by YOUNG SOO LIM26 fall in SBP was lesser in 
Midazolam-Propofol compared with control group.  
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MEAN DIASTOLIC BLOOD PRESSURE 
In our study Mean Diastolic blood pressure showed no significant 
difference between groups before induction, after induction. 
 After intubation there was significant difference in Diastolic blood 
pressure (P<0.01). 
 In control group-86.30. 
 In Midazolam-Propofol group-85.03 
 In Propofol-Propofol group-78.27 
 Mean diastolic blood pressure increased in all three groups after 
intubation. It was found least in Propofol-Propofol  group. 
 In a study by DJAIANI22 et al DBP was higher in Propofol 
coinduction group after induction and after intubation. 
 
MEAN ARTERIAL BLOOD PRESSURE 
In our study MAP found to be significant between groups. 
 Compared to control group, Propofol-Propofol group had least fall 
in MAP after induction and least rise in MAP after intubation. 
 After induction Control Group -77.00 
Propofol-Propofol group-82.24 
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 After intubation Control Group-97.84 
  Propofol-Propofol Group-91.40 
Compared with Midazolam-Propofol group, Propofol- Propofol 
group had least rise in MAP after intubation. 
 Midazolam- Propofol Group-99.00 
 Propofol-Propofol Group-91.40 
 In studies by UMA SRIVASTAVA4 et al after induction MAP 
significantly falls in all three groups. Here 21%decrease was seen in 
control which is more than other groups.4% in Ketamine group which is 
least. No difference existed between Propofol and Midazolam group. 
In studies by GOJENDRA RAJKUMAR25 et al fall in MAP from 
baseline was10.8%  in Midazolam group.8.37% in Ketamine group 
compared to control group. 
 In studies by YOUNG SOO LIM26 et al MAP decreased before 
intubation and 3 minutes after intubation both in conrol group and 
Midazolam group. Decrease  in MAP was lesser in Midazolam group 
(P<0.05). 
 In studies by WM Leong30 et al MAP decreased in both control and 
Propofol auto coinduction group but magnitude of decrease is same in 
both the groups. 
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 Fall in blood pressure in Propofol is due to inhibition of vasomotor 
activity with loss of vasomotor tone and due to decrease ionotropic effect. 
Hypotension exaggerated when given in large doses, rapid injection.  So 
we might found greater fall in blood pressure in control group compared 
to Propofol-Propofol group due to larger usage of Propofol in control 
group. 
 Midazolam also decreases blood pressure by reducing total 
peripheral resistance. So compared to Propofol-Propofol group there was 
fall in blood pressure in Midazolam-Propofol group. 
 
TOTAL DOSE OF PROPOFOL 
In our study total dose of Propofol used was 
 In control group-99.67 
 In Midazolam-Propofol group-40.33 
 In Propofol-Propofol group-69.0 
 This Showed significant difference in Propofol 
requirements.(p<0.001) between groups. 
 There was greater requirement of Propofol in control group 
compared to other groups. Propofol usage was greater in Propofol-
Propofol group compared to Midazolam –Propofol group.  
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This observation might be due to  prior administration of sedative 
results in anxiolysis which reduces sympathetic drive and therefore 
reduces the induction dose to produce hypnosis. The synergistic effect of  
Midazolam and Propofol  was responsible in least usage of Propofol for 
induction  while using  their coinduction technique. 
In a study by KATERIA19 et al   they   found 31.88% reduction  in 
Propofol usage in Propofol autocoinduction.45.37%reduction in 
Midazolam-Propofol coinduction. 
In studies by ANILKUMAR20 et al they found 27.88% reduction in 
Propofol auto coinduction. 
In studies by UMA SRIVASTAVA4 et al  they obtained reduction 
of 40% in Midazolam coinduction and 48% in Propofol autocoinduction 
In studies by MINAXI21 et al  38.26%reduction in Midazolam 
group and 36.10%in Propofol coinduction group. 
In studies by MARTLEW RA28 et al Propofol requirement 
decreased by one third P<0.0001.Dose required for LMA insertion in not 
premedicated group was 3.8mg/kg and in premedicated children 
2.6mg/kg 
In studies by ANDERSON H ROBB7 et al dosage requirements for 
control  was  2.38 mg/kg .In Propofol autocoinduction 1.87 mg/kg , In 
Midazolam –Propofol coinduction 1.87mg/kg  
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Thus in our study we observed reduction in total dose of Propofol 
was greater in Midazolam-Propofol group. Thus  Midazolam-Propofol 
group was cost effective in induction of general anaesthesia, but  we 
found Propofol-Propofol auto coinduction group showed stable 
hemodynamics than other groups. We also observed that after 10 minutes 
of intubation there was no difference between groups. 
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SUMMARY 
This study was done as a randomised single blinded trial, 
conducted in 90 patients of aged 18 – 60 years of both sexes belonging to 
ASA1 & 2 undergoing elective surgery. In this study we compared the 
total dose requirements of Propofol and hemodynamic effects of 
Midazolam-Propofol coinduction with Propofol-Propofol auto coindution 
with control group. We randomly allotted patients in 3 groups of 30 each. 
 Total dose of Propofol required for induction of anaesthesia was 
reduced in Propofol-Propofol group and Midazolam-Propofol 
group compared to control group. Maximum reduction of induction 
dose of Propofol was observed in Midazolam-Propofol group. 
 Hemodynamic alterations seen after induction and after intubation 
was observed in all groups. Incidence of hypotension after 
induction was least in Propofol-Propofol group compared to 
control group. Intubation response was found to be least in 
Propofol-Propofol group compared to control group.  
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CONCLUSION 
We hereby conclude that the usage of coinduction agents decreases the 
dose of induction agents with better hemodynamics. 
 Propofol- Propofol  coinduction  results in better hemodynamics  
than Midazolam-Propofol coinduction. 
 Midazolam-Propofol coinduction reduces Propofol requirement in 
induction of general anaesthesia than Propofol-Propofol 
coinduction and was found to be cost effective.  
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PATIENT CONSENT FORM 
Study Title :  
A Prospective, randomized control study comparing induction dose 
requirements and hemodynamic alterations of midazolam propofol 
coinduction with propofol propofol coinduction using priming principle, 
in patients undergoing elective surgeries. 
                                        
Study Center : Institute of Anaesthesiology and Critical Care, 
Rajiv Gandhi Govt. General Hospital,  
Madras Medical College, 
Chennai - 3.  
         
Participant Name :                    Age:                         Sex:                                I.P.No: 
 
I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the question and all my 
questions and doubts have been answered to my satisfaction.        
I have been explained about the pitfall in the procedure.  I have 
been explained about the safety, advantage and disadvantage of the 
technique. 
I understand that my participation in the study is voluntary and that 
I am free to withdraw at anytime without giving any reason. 
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both 
in respect to current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study. I understand that my 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use 
of any data or results that arise from the study. 
          
Signature / thumb impression of patient  
     Patient name: 
 
 
 
Signature of the investigator: 
Date:        
Place:                                                            
 
 
INFORMATION TO PARTICIPANTS 
Investigator                     : Dr.JAMUNA.S 
Name of the Participant: 
Title  : 
A Prospective,   randomized control study   comparing induction 
dose requirements and hemodynamic alterations in midazolam propofol 
coinduction with propofol propofol coinduction using priming principle, 
in patients undergoing elective surgeries. 
You are invited to take part in this research study. We have got 
approval from the IEC. Your are asked to participate because you satisfy 
the eligibility criteria .We want to compare and study the induction dose 
requirements and hemodynamic alterations in midazolam propofol 
coinduction with propofol propofol coinduction  
What is the Purpose of the Research: 
For elective surgeries, premedication with either midazolam or 
propofol given, followed by propofol induction and intubation. This study 
is done to compare midazolam propofol coinduction with propofol 
propofol coinduction, in patients undergoing elective surgery with respect 
to 
1. Induction dose requirements of propofol, 
2. Hemodynamic alterations, 
 
 The Study Design: 
All the patients in the study will be divided into three groups. 
Group1- Pre medication with inj. glycopyrrolate, inj.fentanyl 
followed by propofol induction. 
Group 2- Pre medication with inj. glycopyrrolate, inj. fentanyl, 
midazolam followed by propofol induction. 
Group 3- Pre medication with inj.glycopyrrolate, inj.fentanyl, 
propofol followed by propofol induction. 
 
 
Benefits                      
Premedication with midazolam /propofol  
1. Reduces propofol induction dose requirements 
2. Decreases the hemodynamic alterations 
3. Reduces the side effects of propofol 
Discomforts and risks 
Hypotension, bradycardia may occur – emergency drugs are 
readily available 
             Apnoea can occur - patient manually ventilated 
             Allergic reactions may occur  
This intervention has been shown to be well tolerated as shown by 
previous studies. And if you do not want to participate you will have 
alternative of setting the standard treatment and your safety is our prime 
concern. 
Time : 
Date : 
Place : 
 
Signature / Thumb Impression of Patient 
Patient Name : 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator  : ____________________________ 
 
 
 
                                                                                     
 
 
 
  
 
 
 
 
 
 
 
 
PROFORMA 
DATE  :                                       
NAME :  
AGE  :                      SEX :                   
DIAGNOSIS : 
SURGICAL PROCEDURE DONE :                                                                      
  
WT :                     CVS :                           RS :                      CNS :                  
ABDOMEN : 
AIRWAY :           MMS :                        IID        TMD                                            
DENTITION : 
PRE OP ASSESSMENT : 
HISTORY : Any Co-morbid illness 
H/O Documented Difficult Airway 
H/O previous surgeries 
MEASURES OF STUDY OUTCOME : 
HR       SBP DBP MAP SPO2 
BASELINE 
BEFORE INDUCTION 
AFTER INDUCTION 
AFTER INTUBATION 
5 MINS AFTER INTUBATION 
10 MINS AFTER INTUBATION 
INDUCTION DOSE REQUIREMENTS OF THREE GROUPS 
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